Levy Caroline S
- SEC CIK
- 0001820042
No open-market purchases or sales filed in the past year.
Current role at each company
- CELH Celsius Holdings, Inc.Directoras of Mar 3, 2026
- NAGE Niagen Bioscience, Inc.Directoras of Dec 2, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Levy Caroline S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CELH Celsius Holdings, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 (view filing) | Mar 11 | 2 days | Levy Caroline SDirector | SSaleCommon Stock, $0.001 par value per share | −70.0K | $26.84 | −$1.88M | −62.1%42.8K after | |
| Mar 14, 2024 (view filing) | Mar 13 | 1 day | Levy Caroline SDirector | SSaleCommon Stock, $0.001 par value per share | −20.0K | $94.77 | −$1.90M | −34.5%37.9K after | |
| Aug 14, 2023 (view filing) | Aug 11 | 3 days | Levy Caroline SDirector | SSale | −30.5K | $171.79 | −$5.24M | −84.7%5.50K after | 2 lots |
| May 25, 2023 (view filing) | May 18 | 7 daysLate | Levy Caroline SDirector | SSale | −2.20K | $134.51 | −$295.9K | −11.1%17.6K after |